| Literature DB >> 25108301 |
Line Hvidberg1, Anette Fischer Pedersen, Christian Nielsen Wulff, Peter Vedsted.
Abstract
BACKGROUND: Differences in cancer awareness between individuals may explain variations in healthcare seeking behaviour and ultimately also variations in cancer survival. It is therefore important to examine cancer awareness and to investigate possible differences in cancer awareness among specific population subgroups. The aim of this study is to assess awareness of cancer symptoms, risk factors and perceived 5-year survival from bowel, breast, ovarian, and lung cancer in a Danish population sample and to analyse the association between these factors and socio-economic position indicators.Entities:
Mesh:
Year: 2014 PMID: 25108301 PMCID: PMC4138385 DOI: 10.1186/1471-2407-14-581
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.430
Figure 1Flow chart of survey population sampling. *Before start of data collection, it was checked whether the persons 1) had a newly established research protection status, 2) had emigrated from Denmark or 3) had passed away.
Response rate
| Total number of persons approached | 11,297 |
| Number of ineligible persons | 1,697a |
| Number of persons who could not be contacted after seven attempts | 1,431 |
|
|
|
| Number of persons who refused or did not complete the interview | 5,169b |
|
|
|
aIncomplete/unobtainable number (n = 1,328); wrong number (n = 326); business/fax number (n = 8); number barred (n = 2); and unable to speak or understand Danish (n = 33).
bRefused to take part (before or after it was known whether or not it was the person eligible for study participation) (n = 4,736); stopped the interview (n = 154); the person eligible for study participation asked to be called back at a later date, but could not be contacted again (n = 141); the persons answering the phone did not want to speak to the interviewer (n = 92); another stated that the person eligible for the study was not available during data collection period (n = 31); and the person stated that he/she was not in the age group anyway (n = 15).
Socio-economic position (SEP) of the respondents (n = 3,000) and of the study base (n = 60,000)
| SEP indicators | Respondents n = 3,000 | Study base n = 60,000 |
| ||
|---|---|---|---|---|---|
| % (n) | % (n) | ||||
|
| <0.01 | ||||
|
| 55.3 | (1,659) | 51.5 | (30,928) | |
|
| 44.7 | (1,341) | 48.5 | (29,072) | |
|
| <0.01 | ||||
|
| 33.3 | (1,000) | 33.3 | (20,000) | |
|
| 50.3 | (1,510) | 46.2 | (27,711) | |
|
| 16.3 | (490) | 20.5 | (12,289) | |
|
| 55.9 | (13.3) | 56.7 | (15.1) | |
|
| <0.01 | ||||
|
| 76.8 | (2,303) | 67.5 | (40,449) | |
|
| 23.2 | (695) | 32.5 | (19,464) | |
|
| <0.01 | ||||
|
| 95.9 | (2,876) | 92.2 | (55,215) | |
|
| 4.1 | (122) | 7.8 | (4,698) | |
|
| <0.01 | ||||
|
| 32.3 | (954) | 22.5 | (12,988) | |
|
| 46.2 | (1,365) | 47.1 | (27,189) | |
|
| 21.5 | (634) | 30.4 | (17,503) | |
|
| <0.01 | ||||
|
| 62.6 | (1,844) | 56.5 | (33,027) | |
|
| 8.1 | (238) | 11.2 | (6,557) | |
|
| 29.3 | (864) | 32.3 | (18,844) | |
|
| <0.01 | ||||
|
| 25.2 | (752) | 20.0 | (11,880) | |
|
| 63.6 | (1,902) | 60.0 | (35,641) | |
|
| 11.2 | (335) | 20.0 | (11,880) | |
|
| 0.066 | ||||
|
| 8.6 | (258) | 7.7 | (4,636) | |
|
| 91.4 | (2,742) | 92.3 | (55,364) | |
|
| |||||
|
| 78.1 | (2,342) | - | - | |
|
| 21.9 | (656) | - | - | |
|
| |||||
|
| 78.0 | (2,334) | - | - | |
|
| 22.0 | (659) | - | - | |
Note: Numbers vary due to missing data.
aChi-square test. One of the assumptions for this test is that observations are independent of each other. Therefore, we tested the difference between respondents and the study base without the respondents i.e. 57,000 persons.
Recognition of less than nine symptoms of cancer and associations with socio-economic position (SEP) indicators
| Awareness of <9 symptoms of cancer | ||
|---|---|---|
| SEP indicators | PR unadj. (95% CI) | PR* adj. (95% CI) |
|
| ||
|
| 1.00 | 1.00 |
|
|
|
|
|
| ||
|
| 1.00 | 1.00 |
|
| 0.92 (0.84-1.01) |
|
|
| 1.08 (0.96-1.21) | 0.94 (0.83-1.06) |
|
| ||
|
| 1.00 | 1.00 |
|
| 1.08 (0.98-1.18) | 1.08 (0.98-1.18) |
|
| ||
|
| 1.00 | 1.00 |
|
|
|
|
|
| ||
|
| 1.00 | 1.00 |
|
|
|
|
|
|
|
|
|
| ||
|
| 1.00 | 1.00 |
|
|
|
|
|
| 1.08 (0.98-1.19) | 1.13 (0.99-1.29)** |
|
| ||
|
| 1.00 | 1.00 |
|
|
|
|
|
|
|
|
|
| ||
|
| 1.00 | 1.00 |
|
| 1.02 (0.88-1.19) | 1.07 (0.92-1.25) |
|
| ||
|
| 1.00 | 1.00 |
|
|
|
|
|
| ||
|
| 1.00 | 1.00 |
|
|
| 1.02 (0.93-1.13) |
Note: Prevalence ratios (PR) with 95% confidence intervals (CI). Numbers in bold are significant results.
*Adjusted for gender, age, marital status, ethnicity, educational level, cancer diagnosis within the past 10 years, close relative(s) with cancer and self-rated health.
**Not adjusted for educational level due to intermediary associations between the variables.
Recognition of less than nine risk factors for cancer and associations with socio-economic position (SEP) indicators
| Awareness of <9 risk factors for cancer | ||
|---|---|---|
| SEP indicators | PR unadj. (95% CI) | PR* adj. (95% CI) |
|
| ||
|
| 1.00 | 1.00 |
|
|
|
|
|
| ||
|
| 1.00 | 1.00 |
|
|
|
|
|
|
|
|
|
| ||
|
| 1.00 | 1.00 |
|
|
| 1.05 (0.96-1.14) |
|
| ||
|
| 1.00 | 1.00 |
|
| 1.14 (0.97-1.35) | 1.09 (0.91-1.30) |
|
| ||
|
| 1.00 | 1.00 |
|
|
|
|
|
|
|
|
|
| ||
|
| 1.00 | 1.00 |
|
|
|
|
|
|
|
|
|
| ||
|
| 1.00 | 1.00 |
|
|
|
|
|
|
|
|
|
| ||
|
| 1.00 | 1.00 |
|
| 1.02 (0.89-1.17) | 1.06 (0.93-1.21) |
|
| ||
|
| 1.00 | 1.00 |
|
| 0.98 (0.89-1.07) | 0.94 (0.86-1.03) |
|
| ||
|
| 1.00 | 1.00 |
|
|
| 1.06 (0.98-1.16) |
Note: Prevalence ratios (PR) with 95% confidence intervals (CI). Numbers in bold are significant results.
*Adjusted for gender, age, marital status, ethnicity, educational level, cancer diagnosis within the past 10 years, close relative(s) with cancer and self-rated health.
**Not adjusted for educational level due to intermediary associations between the variables.
Lack of awareness of growing risk of cancer with age and associations with socio-economic position (SEP) indicators
| Lack of awareness of growing risk of cancer with age | ||
|---|---|---|
| SEP indicators | PR unadj. (95% CI) | PR* adj. (95% CI) |
|
| ||
|
| 1.00 | 1.00 |
|
|
|
|
|
| ||
|
| 1.00 | 1.00 |
|
| 0.98 (0.94-1.02) | 0.95 (0.86-1.04) |
|
| 1.00 (0.94-1.06) | 0.92 (0.81-1.05) |
|
| ||
|
| 1.00 | 1.00 |
|
|
| 1.05 (0.95-1.16) |
|
| ||
|
| 1.00 | 1.00 |
|
|
| 1.08 (0.88-1.34) |
|
| ||
|
| 1.00 | 1.00 |
|
|
|
|
|
|
|
|
|
| ||
|
| 1.00 | 1.00 |
|
|
| 1.06 (0.91-1.23)** |
|
| 1.01 (0.97-1.06) | 1.01 (0.88-1.16)** |
|
| ||
|
| 1.00 | 1.00 |
|
|
|
|
|
|
|
|
|
| ||
|
| 1.00 | 1.00 |
|
| 1.00 (0.93-1.07) | 1.00 (0.86-1.16) |
|
| ||
|
| 1.00 | 1.00 |
|
| 0.98 (0.94-1.03) | 0.98 (0.88-1.09) |
|
| ||
|
| 1.00 | 1.00 |
|
|
| 1.03 (0.93-1.14) |
Note: Prevalence ratios (PR) with 95% confidence intervals (CI). Numbers in bold are significant results.
*Adjusted for gender, age, marital status, ethnicity, educational level, cancer diagnosis within the past 10 years, close relative(s) with cancer and self-rated health.
**Not adjusted for educational level due to intermediary associations between the variables.
Figure 2Proportion of respondents underestimating, correctly estimating and overestimating the 5-year survival from bowel, breast, ovarian, and lung cancer*. *Missing data for awareness of 5-year survival: bowel cancer: n = 154, breast cancer: n = 88, ovarian cancer: n = 194, lung cancer: n = 98, including response categories don’t know and did not answer.
Underestimation/overestimation of 5-year survival from bowel, breast, ovarian and lung cancer and associations with socio-economic position (SEP) indicators
| Underestimation/overestimation of 5-year survival | ||||||||
|---|---|---|---|---|---|---|---|---|
| Bowel cancer | Breast cancer | Ovarian cancer | Lung cancer | |||||
| SEP indicators | PR unadj. (95% CI) | PR* adj. (95% CI) | PR unadj. (95% CI) | PR* adj. (95% CI) | PR unadj. (95% CI) | PR* adj. (95% CI) | PR unadj. (95% CI) | PR* adj. (95% CI) |
|
| ||||||||
|
| 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
|
| 1.02 (0.95-1.08) | 1.03 (0.96-1.09) | 0.98 (0.91-1.05) | 0.97 (0.90-1.05) |
|
|
|
|
|
| ||||||||
|
| 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
|
| 0.96 (0.90-1.03) | 0.96 (0.89-1.03) | 1.03 (0.95-1.11) | 1.02 (0.93-1.10) | 0.99 (0.97-1.02) | 0.99 (0.96-1.01) | 1.05 (1.01-1.09) |
|
|
| 0.92 (0.84-1.02) | 0.93 (0.83-1.03) |
| 1.11 (0.99-1.24) | 1.00 (0.97-1.04) | 0.99 (0.96-1.03) | 1.08 (1.02-1.14) |
|
|
| ||||||||
|
| 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
|
| 1.02 (0.95-1.10) | 1.03 (0.96-1.11) | 1.02 (0.94-1.11) | 0.99 (0.91-1.08) | 1.01 (0.99-1.04) | 1.00 (0.97-1.03) | 0.98 (0.94-1.02) | 0.97 (0.93-1.02) |
|
| ||||||||
|
| 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
|
| 0.97 (0.82-1.15) | 0.98 (0.82-1.17) | 1.11 (0.94-1.31) | 1.08 (0.90-1.29) | 0.95 (0.88-1.02) | 0.93 (0.86-1.01) | 1.03 (0.94-1.12) | 1.02 (0.93-1.12) |
|
| ||||||||
|
| 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
|
| 1.03 (0.95-1.10) | 1.02 (0.95-1.10) | 1.02 (0.94-1.11) | 1.02 (0.94-1.11) |
|
| 1.01 (0.96-1.05) | 1.00 (0.96-1.04) |
|
| 1.01 (0.92-1.11) | 1.01 (0.92-1.11) | 1.08 (0.98-1.19) | 1.04 (0.94-1.16) |
| 1.03 (1.00-1.07) | 1.03 (0.99-1.09) | 1.02 (0.97-1.07) |
|
| ||||||||
|
| 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
|
| 1.08 (0.96-1.21) | 0.99 (0.88-1.12)** |
|
| 0.97 (0.92-1.02) |
| 1.00 (0.93-1.07) | 1.00 (0.93-1.07)** |
|
| 0.98 (0.91-1.06) | 0.98 (0.88-1.09)** |
| 1.12 (0.99-1.26)** | 0.98 (0.95-1.01) | 1.00 (0.97-1.02)** | 1.04 (1.00-1.08) | 0.98 (0.92-1.03)** |
|
| ||||||||
|
| 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
|
|
|
| 1.00 (0.92-1.08) | 1.00 (0.92-1.09)** | 1.02 (0.99-1.05) | 1.02 (0.93-1.12)** | 1.00 (0.96-1.04) | 1.00 (0.96-1.04)** |
|
|
|
| 1.12 (0.99-1.26) | 1.08 (0.95-1.23)** | 1.02 (0.97-1.06) | 1.02 (0.88-1.19)** | 0.99 (0.92-1.05) | 0.98 (0.91-1.04)** |
|
| ||||||||
|
| 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
|
| 1.04 (0.92-1.16) | 1.00 (0.89-1.13) | 0.90 (0.80-1.01) | 0.94 (0.83-1.06) | 0.99 (0.95-1.03) | 0.99 (0.95-1.04) | 0.99 (0.93-1.05) | 0.99 (0.93-1.06) |
|
| ||||||||
|
| 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
|
|
|
| 1.07 (0.99-1.16) | 1.07 (0.98-1.16) | 1.00 (0.97-1.03) | 1.00 (0.97-1.02) | 1.01 (0.97-1.06) | 1.00 (0.96-1.04) |
|
| ||||||||
|
| 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
|
| 1.05 (0.97-1.13) | 1.04 (0.97-1.13) | 0.98 (0.90-1.07) | 0.97 (0.89-1.06) | 1.02 (0.99-1.05) | 1.01 (0.98-1.03) | 1.01 (0.97-1.05) | 1.01 (0.97-1.05) |
Note: Prevalence ratios (PR) with 95% confidence intervals (CI). Numbers in bold are significant results.
*Adjusted for gender, age, marital status, ethnicity, educational level, cancer diagnosis within the past 10 years, close relative(s) with cancer and self-rated health.
**Not adjusted for educational level due to intermediary associations between the variables.